Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Aleksander Mendyk, Paweł K Tuszyński, Sebastian Polak & Renata Jachowicz. (2013) Generalized in vitro-in vivo relationship (IVIVR) model based on artificial neural networks. Drug Design, Development and Therapy 7, pages 223-232.
Read now
Read now
Paul R. Seo, Vinod P. Shah & James E. Polli. (2002) Novel Metrics to Compare Dissolution Profiles. Pharmaceutical Development and Technology 7:2, pages 257-265.
Read now
Read now
James E. Polli. (1999) Dependence of In Vitro-In Vivo Correlation Analysis Acceptability on Model Selections. Pharmaceutical Development and Technology 4:1, pages 89-96.
Read now
Read now
Natalie D. Eddington, Muhammad Ashraf, Larry L. Augsburger, James L. Leslie, Michael J. Fossler, Lawrence J. Lesko, Vinod P. Shah & Gurvinder Singh Rekhi. (1998) Identification of Formulation and Manufacturing Variables That Influence In Vitro Dissolution and In Vivo Bioavailability of Propranolol Hydrochloride Tablets. Pharmaceutical Development and Technology 3:4, pages 535-547.
Read now
Read now
Articles from other publishers (28)
Bruno Solis-Cruz, Daniel Hernandez-Patlan, Elvia A. Morales Hipólito, Guillermo Tellez-Isaias, Alejandro Alcántara Pineda & Raquel López-Arellano. (2023) Discriminative Dissolution Method Using the Open-Loop Configuration of the USP IV Apparatus to Compare Dissolution Profiles of Metoprolol Tartrate Immediate-Release Tablets: Use of Kinetic Parameters. Pharmaceutics 15:9, pages 2191.
Crossref
Crossref
Asmita Adhikari, Paul R. Seo & James E. Polli. (2023) Dissolution-Hollow Fiber Membrane (D-HFM) System to Anticipate Biopharmaceutics Risk of Tablets and Capsules. Journal of Pharmaceutical Sciences 112:3, pages 751-759.
Crossref
Crossref
Hairui Xie, Lili Zhou, Zhijiang Chen & Hong Zhao. (2021) The Effect of Wnt Family Member 5a Gene Silencing on the Proliferation of Achondroplasia Using a DNAzymes-CoOOH Nanocomposite. Journal of Biomedical Nanotechnology 17:7, pages 1426-1434.
Crossref
Crossref
Ana Catarina Faria-Silva, Ana Margarida Costa, Andreia Ascenso, Helena Margarida Ribeiro, Joana Marto, Lídia Maria Gonçalves, Manuela Carvalheiro & Sandra Simões. 2020. Nanocosmetics. Nanocosmetics
59
77
.
Susumu Takeuchi, Yasuhiro Tsume, Gregory E. Amidon & Gordon L. Amidon. (2014) Evaluation of a Three Compartment In Vitro Gastrointestinal Simulator Dissolution Apparatus to Predict In Vivo Dissolution. Journal of Pharmaceutical Sciences 103:11, pages 3416-3422.
Crossref
Crossref
Sandra Cvijić, Jelena Parojčić & Peter Langguth. (2014) Viscosity-mediated negative food effect on oral absorption of poorly-permeable drugs with an absorption window in the proximal intestine: In vitro experimental simulation and computational verification. European Journal of Pharmaceutical Sciences 61, pages 40-53.
Crossref
Crossref
Leon Shargel & Isadore KanferIsadore Kanfer, Roderick Walker, Raimar Löbenberg & Nádia Bou-Chacra. 2013. Generic Drug Product Development. Generic Drug Product Development
51
94
.
Zi-qiang Li, Xin He, Xiumei Gao, Yan-yan Xu, Yue-fei Wang, Hui Gu, Rui-feng Ji & Shu-jun Sun. (2011) Study on dissolution and absorption of four dosage forms of isosorbide mononitrate: Level A in vitro–in vivo correlation. European Journal of Pharmaceutics and Biopharmaceutics 79:2, pages 364-371.
Crossref
Crossref
Jim E. RiviereMarilyn Martinez. 2011. Comparative Pharmacokinetics. Comparative Pharmacokinetics
315
346
.
Shein-Chung ChowIain J. McGilveray. 2010. Encyclopedia of Biopharmaceutical Statistics. Encyclopedia of Biopharmaceutical Statistics
170
185
.
Hans Lennernäs & Bertil Abrahamsson. (2005) The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension. Journal of Pharmacy and Pharmacology 57:3, pages 273-285.
Crossref
Crossref
Yongsheng Yang & Lawrence X. Yu. 2009. Developing Solid Oral Dosage Forms. Developing Solid Oral Dosage Forms
289
308
.
Bertil Abrahamsson & Hans Lennernäs. 2008. Drug Bioavailability. Drug Bioavailability
521
558
.
Marija Tubic-Grozdanis, Michael B. Bolger & Peter Langguth. (2008) Application of Gastrointestinal Simulation for Extensions for Biowaivers of Highly Permeable Compounds. The AAPS Journal 10:1, pages 213-226.
Crossref
Crossref
Sau Lawrence Lee, Andre S. Raw & Lawrence Yu. 2008. Biopharmaceutics Applications in Drug Development. Biopharmaceutics Applications in Drug Development
47
74
.
H. Lennernäs & B. Abrahamsson. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
971
988
.
Sarfaraz Niazi. 2006. Handbook of Preformulation. Handbook of Preformulation
141
195
.
Saeed A Qureshi & Javad Shabnam. (2003) Applications of a new device (spindle) for improved characterization of drug release (dissolution) of pharmaceutical products. European Journal of Pharmaceutical Sciences 19:4, pages 291-297.
Crossref
Crossref
Marilyn N. Martinez & Gordon L. Amidon. (2013) A Mechanistic Approach to Understanding the Factors Affecting Drug Absorption: A Review of Fundamentals. The Journal of Clinical Pharmacology 42:6, pages 620-643.
Crossref
Crossref
Larry Augsburger. 2002. Modern Pharmaceutics, Fourth Edition. Modern Pharmaceutics, Fourth Edition.
Samar Al-Behaisi, István Antal, György Morovján, József Szúnyog, Sándor Drabant, Sylvia Marton & Imre Klebovich. (2002) In vitro simulation of food effect on dissolution of deramciclane film-coated tablets and correlation with in vivo data in healthy volunteers. European Journal of Pharmaceutical Sciences 15:2, pages 157-162.
Crossref
Crossref
Bipin Mistry, James L. Leslie & Natalie D. Eddington. (2002) Influence of input rate on the stereospecific and nonstereospecific first pass metabolism and pharmacokinetics of metoprolol extended release formulations. Chirality 14:4, pages 297-304.
Crossref
Crossref
Kimberley Jackson, David Young & Sonia Pant. (2000) Drug–excipient interactions and their affect on absorption. Pharmaceutical Science & Technology Today 3:10, pages 336-345.
Crossref
Crossref
H. Mahayni, G.S. Rekhi, R.S. Uppoor, P. Marroum, A.S. Hussain, L.L. Augsburger & N.D. Eddington. (2000) Evaluation of “External” Predictability of an In Vitro–In Vivo Correlation for an Extended‐Release Formulation Containing Metoprolol Tartrate. Journal of Pharmaceutical Sciences 89:10, pages 1354-1361.
Crossref
Crossref
Natalie D. Eddington, Guvinder Singh Rekhi, Larry J. Lesko & Larry L. Augsburger. (2015) Scale-up effects on dissolution and bioavailability of propranolol hydrochloride and metoprolol tartrate tablet formulations. AAPS PharmSciTech 1:2, pages 63-71.
Crossref
Crossref
Natalie D. Eddington, Guvinder Singh Rekhi, Larry J. Lesko & Larry L. Augsburger. (2000) Scale-up effects on dissolution and bioavailability of propranolol hydrochloride and metoprolol tartrate tablet formulations. AAPS PharmSciTech 1:2, pages 63-71.
Crossref
Crossref
Mark J. Ginski, Rajneesh Taneja & James E. Polli. (1999) Prediction of dissolution-absorption relationships from a continuous dissolution/Caco-2 system. AAPS PharmSci 1:2, pages 27-38.
Crossref
Crossref
James E. Polli, G. Singh Rekhi, Larry L. Augsburger & Vinod P. Shah. (1997) Methods to Compare Dissolution Profiles and a Rationale for Wide Dissolution Specifications for Metoprolol Tartrate tablets†. Journal of Pharmaceutical Sciences 86:6, pages 690-700.
Crossref
Crossref